Real‐world evaluation of capillary microsampling for drug monitoring of anti‐seizure medications
Epilepsia · 2026
DOI: 10.1002/epi.70439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Chiara Cancellerini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Drug Monitoring, Anticonvulsants, Epilepsy, Blood Specimen Collection. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lega Italiana Contro l'Epilessia.
Abstract (Originalsprache)
Objective
Capillary microsampling offers a minimally invasive alternative to venipuncture for therapeutic drug monitoring (TDM) of anti‐seizure medications (ASMs). We evaluated the feasibility and reliability of volumetric absorptive microsampling (VAMS) and quantitative dried blood spot (qDBS) devices for ambulatory self‐collection and at‐home use in persons with epilepsy (PwE).
Methods
PwE attending the Epilepsy Centre of the IRCCS‐Istituto delle Scienze Neurologiche di Bologna (Italy) were enrolled between October 2023 and October 2024. Participants performed supervised self‐collection using VAMS and qDBS in ambulatory setting and at‐home self‐collection with VAMS devices. Sample quality, delivery success, and patient‐reported outcomes (ease, pain, and clarity of instructions) were recorded. Carbamazepine, lacosamide, lamotrigine, and levetiracetam were quantified using a validated ultra‐high performance liquid chromatography‐tandem mass spectrometry (UHPLC–MS/MS) method. Reliability was assessed by comparing at‐home VAMS with ambulatory VAMS and cross‐validating qDBS with VAMS and venous plasma samples using Bland–Altman analysis and linear regression.
Results
A total of 105 PwE (66% female, mean age 41 years) performed at‐home and ambulatory self‐collection using VAMS and qDBS devices. Most at‐home VAMS samples (88%) were received by the laboratory within 7 days, and 86.8% met high‐quality criteria. For lacosamide, lamotrigine, and levetiracetam, we found strong correlations between at‐home and ambulatory VAMS (Pearson's r ranging from .88 to .98) and low mean bias (60 years impacted sampling quality, particularly for qDBS ( p = .04). Significance VAMS‐based self‐collection is feasible and reliable for at‐home TDM, provided that high‐quality sampling is ensured. qDBS represents a reliable alternative for ambulatory monitoring. Future work should focus on optimizing sampling procedures for older adults and improving logistics for home‐based microsampling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
- IRCCS, Istituto delle Scienze Neurologiche di Bologna, Full Member of the European Reference Network for Rare and Complex Epilepsies (EpiCARE), Bologna, Italy.
- Department of Chemistry "G. Ciamician", University of Bologna, Bologna, Italy.
ORCID-Profile: Chiara Cancellerini, Alice Caravelli, Martina Soldà, Erika Esposito, Luca Vignatelli, Barbara Mostacci, Jessica Fiori, Francesca Bisulli, Laura Licchetta
Förderung
- Lega Italiana Contro l'Epilessia
Zitieren
APA
Cancellerini, C., Caravelli, A., Soldà, M., Esposito, E., Vignatelli, L., Mostacci, B., Fiori, J., Bisulli, F., & Licchetta, L. (2026). Real‐world evaluation of capillary microsampling for drug monitoring of anti‐seizure medications. Epilepsia. https://doi.org/10.1002/epi.70439
Vancouver
Cancellerini C, Caravelli A, Soldà M, Esposito E, Vignatelli L, Mostacci B, et al. Real‐world evaluation of capillary microsampling for drug monitoring of anti‐seizure medications. Epilepsia. 2026. doi:10.1002/epi.70439
BibTeX
@article{Cancellerini2026,
author = {Cancellerini, Chiara and Caravelli, Alice and Soldà, Martina and Esposito, Erika and Vignatelli, Luca and Mostacci, Barbara and Fiori, Jessica and Bisulli, Francesca and Licchetta, Laura},
title = {Real‐world evaluation of capillary microsampling for drug monitoring of anti‐seizure medications},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70439}
}
EUVIMED